Morepen Laboratories Secures ₹500 Million in Total Loan Facilities, Approves New Funding from Qatar National Bank
Updated: May 23, 2025 10:15
Image Source: Dalal Street Investment Journal
Morepen Laboratories Ltd. has strengthened its financial position by securing total loan facilities amounting to ₹500 million, with its Board recently approving a new loan facility from Qatar National Bank. This move is part of the company’s ongoing efforts to support its expanding operations and fuel its ambitious growth targets.
Key Highlights:
Total Loan Facilities: Morepen Laboratories has consolidated its loan facilities to a total of ₹500 million, which includes various term loans and working capital arrangements from multiple banks.
New Approval from Qatar National Bank: The Board of Directors has given the green light for a fresh loan facility from Qatar National Bank, further diversifying the company’s funding sources and strengthening its financial flexibility.
Recent Loan Agreements: In addition to the Qatar National Bank facility, Morepen recently approved a ₹250 million term loan from Shinhan Bank at a floating interest rate of 9.25% per annum, and a substantial working capital facility from Kotak Mahindra Bank amounting to ₹990 million, supporting both short-term and long-term business needs.
Growth and Expansion: The infusion of new capital is expected to accelerate Morepen’s expansion in its core pharmaceutical and medical devices businesses, helping the company move closer to its revenue target of ₹5,000 crore by FY30.
Strong Investor Confidence: The company’s recent successful QIP fundraise and partnerships with marquee global investors reflect robust market confidence in Morepen’s strategic direction and growth prospects.
These financial developments position Morepen Laboratories for sustained growth, operational expansion, and increased competitiveness in the pharmaceutical sector.